A bright chemical "may facilitate brain cancer surgery"

Naseem News The results of a scientific experiment suggest that the chemical secretions responsible for the acquisition of pink brain tumors could help clear cancerous tumors safely.

Scientists have given a number of patients suspected of having a rapidly growing tumor in brain cells containing a 5-ALA compound, a substance abundantly present in rapidly growing cancer cells.

Tumors are characterized by glial cells or glands because they infect cells of the same name. These cells are found in the connective tissues responsible for joining or connecting tissues and organs.

Experience has revealed that this substance, predominantly pink, was found in people with the most serious cancers.

The researchers hope the secretions will help surgeons distinguish cancer cells from healthy brain tissue.

The treatment of these tumors, the most common type of cancerous brain tumor at the origin of the death of British Minister Tessa Joel, requires surgery to remove as much tumor as possible, but the diagnosis of this type of cancer is often inaccurate.

In the new trial, 99 patients suspected of developing fast-growing tumors in brain cells took a 5-ALA drug before surgery.

Researchers previously said the substance was found in fast-growing cancer cells because of the lack of enzyme needed for the breakdown of this chemical.

Surgeons used a microscope to see the tissue lit while cleaning the brain tumors.

During the surgeries, these tissues appeared in 85 patients, including 81 with serious injuries, a patient with a low-risk injury, and the inability to assess the degree of injury of three patients.

Of the patients who did not have the tissue illuminated during surgery, 14 were infected, there were seven patients with a low degree of infection while the other seven were not recognized.

"It is urgent to find what helps brain surgeons while the patient is sitting down to discover the parts most affected by the disease," said Christina Corian, associate professor at the Brain Tumors Research Center of the United States. Bristol University.

"What's useful in ALA 5, is that they reveal tumors during surgeons' work," she said.

The researchers indicated that the study focused primarily on people with advanced glaucoma, but further efforts were needed to expand the research sample base and to prepare for a more in-depth study involving more patients with advanced glaucoma. lower risk of these tumors, so that's the new method.

It is necessary to test other types of orientation documents that show surgeons less dangerous cancer cells and help them distinguish them from healthy brain tissue.

The next steps in this trial include the use of 5-ALA in children with brain cancer or to help surgeons identify scar tissue in patients who have relapsed after treatment for the cancer.

"Identifying the most dangerous cancerous tumors for good brain tissue immediately helps surgeons erase the tumor as much as possible while preserving healthy tissue in the brain," said Paul Bernan, a professor at the British Cancer Research Center.

He added that "light guiding materials also reduce the burden of follow-up treatment because the remaining parts of tumor tumors after surgery require more radiation or chemotherapy.

Earlier this year, the National Institute of Health and Clinical Excellence approved the use of 5-ALA prior to surgery in people with brain cancer.

The research was presented at a conference of the National Cancer Research Institute, which takes place from 4 to 6 of the month of this month.

————————

You can receive notifications on the most important topics after downloading the latest version of the BBC Arabic application on your mobile phone.